Navigation Links
The Case for Trial Lawyers

By Michael F. Barrett, Esq.

PHILADELPHIA, July 8 /PRNewswire-USNewswire/ -- The following is by Michael F. Barrett, Esq.:

"Kill all the lawyers" -- at your own peril

When you heard the news not long ago that three prominent attorneys who had made their reputations suing corporations had pled guilty to either attempted judicial bribery or a kickback scheme, no doubt Shakespeare's oft-quoted line, "The first thing we do, let's kill all the lawyers," came to mind.

But what you probably don't realize is that the line, taken in its dramatic context, really means that if you want anarchy you must first get rid of lawyers.

Indeed, while it has become fashionable in some corporate and political quarters to demonize trial lawyers, your medicine cabinet, your house, your car, your highways, your workplace and the world in which you live are far safer today because of the efforts of trial lawyers to hold businesses and governments responsible and accountable for their actions. Trial lawyers, says attorney and former Democratic presidential candidate John Edwards, are our last defense against greedy corporations.

Don't believe him? Do you remember flammable children's pajamas? Deadly cribs? Asbestos? Even Little League and Pop Warner Football games before helmets were required. They have all disappeared, or been vastly improved, thanks to civil lawsuits.

Unfortunately, however, today's legal and political climate is edging us closer towards the anarchy to which Shakespeare cleverly alluded. In March the U.S. Supreme Court ruled that the makers of medical devices who have received FDA approval are protected from lawsuits, no matter what goes wrong with their devices. It now appears the same "pre-emption" protection will soon be afforded drug makers -- the same drug manufacturers who supply the studies on which the FDA bases its decisions. These are the same drug makers who often drag their feet in reporting adverse results and in pulling dangerous drugs off the market.

Do you believe that the understaffed and overwhelmed FDA, which until recently believed lawsuits were an essential additional safety check, should be the sole judge of whether foods, drugs and medical devices are safe for you?

Tell that to the more than 3,000 women and their families who have sued Johnson & Johnson alleging that its Ortho Evra birth-control patch had caused heart attacks, strokes and even death. Rather than delivering less estrogen than a standard daily birth control pill, as the FDA-approved label indicated, the patch actually delivered more and increased the risk of blood clots. Johnson & Johnson, based on its own studies, knew that -- but delayed telling the FDA and the public.

Or tell the hundreds mostly dialysis patients who suffered allergic reactions, including several who died, after taking an apparently tainted blood thinner, heparin. The manufacturer withdrew the drug earlier this year after questions arose about its Chinese supplier -- which apparently had never been inspected by the FDA.

Meanwhile, in Pennsylvania, tort reform -- including proposals to place caps on non-medical damages -- continues to be a popular topic. But, with lawsuits against Pennsylvania doctors declining 38 percent between 2003 and 2006, the medical malpractice crisis in Pennsylvania is over in Gov. Rendell's view. One reason for the decline: a certificate of merit requirement that prevents malpractice lawsuits from proceeding unless a licensed doctor signs off on the validity of the claim. Nonetheless, even though the Institute on Medicine says nearly 100,000 die as a result of medical mistakes each year, hospitals are lobbying to completely shield their doctors from lawsuits.

Trial lawyers strongly endorse legislation that quashes frivolous lawsuits. But if you believe that legitimate litigation plays a crucial role in protecting patients and consumers, let your state and federal legislators know you are opposed to pre-empting litigation rights and capping non-economic damages.

Michael F. Barrett, Esq., Managing Shareholder of Salt Mongeluzzi Barrett & Bendesky, P.C., is the newly-elected President of the Philadelphia Trial Lawyers Association, a non-profit advocacy organization.

SOURCE Saltz, Mongeluzzi, Barrett & Bendesky P.C.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New clinical trial for patients with asbestos-associated lung cancer
2. Austin Company Makes a Splash at U.S. Olympic Team Swimming Trials
3. Blood Substitute Found Safe in Large Phase III Trial
4. The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation
5. Evalve MitraClip: Clinical trial of nonsurgical repair for severe mitral valve regurgitation
6. Molecular insight begins Trofex Phase 1 trial for detection of metastatic prostate cancer
7. New insight into RA patient priorities and motivators for clinical trial involvement
8. Molecular insight begins Trofex Ph. 1 trial for detection of metastatic prostate cancer
9. Industrial Control Repair Named Honda of America Manufacturings 2007 Supplier of the Year
10. Organizers of cancer clinical trials are neglecting teenagers and young adults
11. Bradmer receives FDA approval to proceed with Phase III clinical trial
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in ... ways they remain in the eye of the beholder, according to experts who offered ... The American Journal of Managed Care. For the full issue, click here . ...
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
Breaking Medicine Technology: